Business · Markets · 8 hrs ago

Swiss SMI rises 1.5% as defensive shares lead gains

Swiss SMI rises 1.5% as defensive shares lead gains

Switzerland's SMI rose 1.5% on Wednesday, closing at 14,129 points.

Defensive healthcare and pharmaceutical shares led gains, as demand for medicines tends to depend less on the economy.

Lonza shares climbed 3.4% after the company raised its financial targets at an investor event.

Sandoz, Galderma, Alcon, Roche, Novartis and Nestlé also gained, while financial and technology shares fell.

US consumer prices rose more than expected in September, partly because of higher petrol prices and a strong economy.

The inflation figures renewed concerns about interest rates, and major US stock markets fell; European markets ended higher, but with smaller gains than Switzerland's.

1 source

Related

What people are saying

ExpertExpert
The concerns about interest rates are likely to have gained renewed sharpness now
via Watson